Prestige Consumer Healthcare Inc (PBH)
70.14
+0.01
(+0.01%)
USD |
NYSE |
Apr 25, 16:00
70.09
-0.05
(-0.07%)
Pre-Market: 20:00
Prestige Consumer Healthcare Cash from Operations (TTM): 241.01M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 241.01M |
September 30, 2023 | 224.48M |
June 30, 2023 | 219.56M |
March 31, 2023 | 229.72M |
December 31, 2022 | 233.86M |
September 30, 2022 | 245.21M |
June 30, 2022 | 248.86M |
March 31, 2022 | 259.92M |
December 31, 2021 | 255.88M |
September 30, 2021 | 238.81M |
June 30, 2021 | 229.76M |
March 31, 2021 | 235.61M |
December 31, 2020 | 232.65M |
September 30, 2020 | 241.42M |
June 30, 2020 | 239.50M |
March 31, 2020 | 217.12M |
December 31, 2019 | 211.84M |
September 30, 2019 | 197.18M |
June 30, 2019 | 186.21M |
March 31, 2019 | 189.28M |
December 31, 2018 | 192.88M |
September 30, 2018 | 196.68M |
June 30, 2018 | 211.84M |
March 31, 2018 | 210.11M |
December 31, 2017 | 163.20M |
Date | Value |
---|---|
September 30, 2017 | 156.13M |
June 30, 2017 | 151.49M |
March 31, 2017 | 148.67M |
December 31, 2016 | 181.01M |
September 30, 2016 | 186.80M |
June 30, 2016 | 184.09M |
March 31, 2016 | 176.31M |
December 31, 2015 | 188.56M |
September 30, 2015 | 189.79M |
June 30, 2015 | 170.10M |
March 31, 2015 | 156.26M |
December 31, 2014 | 134.86M |
September 30, 2014 | 113.04M |
June 30, 2014 | 118.46M |
March 31, 2014 | 111.58M |
December 31, 2013 | 117.59M |
September 30, 2013 | 132.83M |
June 30, 2013 | 145.66M |
March 31, 2013 | 137.60M |
December 31, 2012 | 120.34M |
September 30, 2012 | 94.36M |
June 30, 2012 | 66.75M |
March 31, 2012 | 67.45M |
December 31, 2011 | 73.00M |
September 30, 2011 | 77.32M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
186.21M
Minimum
Jun 2019
259.92M
Maximum
Mar 2022
230.98M
Average
233.86M
Median
Dec 2022
Cash from Operations (TTM) Benchmarks
NovaBay Pharmaceuticals Inc | -4.131M |
Palatin Technologies Inc | -26.54M |
iBio Inc | -18.89M |
Theriva Biologics Inc | -19.00M |
Oragenics Inc | -7.291M |